ProMIS Neurosciences, Inc. Share Price Toronto S.E.
Equities
PMN
CA74346M4065
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 46.45M 33.97M 2.84B |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.8M -2.32B | Net income 2025 * | -46M -33.65M -2.81B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.63
x | P/E ratio 2025 * |
-1.64
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.67% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 13/21/13 |
Neil Cashman
FOU | Founder | 72 | 23/04/23 |
Eugene Williams
CHM | Chairman | 64 | 29/15/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 08/14/08 |
Neil Cashman
FOU | Founder | 72 | 23/04/23 |
Neil Warma
CEO | Chief Executive Officer | 61 | 13/21/13 |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 108B | |
+10.88% | 104B | |
+1.28% | 22.33B | |
-12.78% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.82% | 17.64B | |
+4.21% | 14.05B | |
+34.85% | 12.51B |